Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single ... is expected to offer Trelegy at a discount to the sum cost of the individual therapies, rather than seek a premium.

European regulators have refused to back GlaxoSmithKline’s daily triple therapy Trelegy Ellipta for asthma, denying a label extension because there was no evidence to show a reduction of flare-ups.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The cheapest states are: The average cost of car insurance is $6,045 a year for an 18-year-old driver. It’s $2,204 a year for a 30-year-old and $1,847 a year for a 60-year-old for full coverage ...

Meanwhile GSK's lead inhalers include Trelegy Ellipta, projected to bring $3.3bn ... This in turn could actually increase the carbon cost of treatment. “We encourage prescribers to take a ...

Check the price of copper with Money Metals Exchange's interactive live and historical chart. The chart below allows you to check copper spot prices dating back 20 years up to the current date. Copper ...

The real-time price of Brent crude oil is at $76.59 per barrel, and the price of WTI crude oil is at $74.07 per barrel. Oil prices are customarily quoted in dollars (USD) around the world, not only in ...

The cost of your trip has a significant impact on how much you pay for travel insurance. For example, the average cost of travel insurance is only $61 for a $1,000 trip but a tad over $1,200 for a ...

Check the price of rhodium with Money Metals Exchange's interactive live and historical chart. The chart below allows you to check rhodium spot prices dating back 25 years up to the current date.

The 2024 homebuying season was a tough one thanks to high mortgage rates and rising home prices. Will 2025 be any easier for homebuyers? While home prices probably won't drop anytime soon ...

Pfizer, Inc. and Sun Pharmaceutical Industries Ltd. GlaxoSmithKline plc has entered into a partnership with Innoviva, Inc. to develop and market several respiratory medications, including Trelegy ...